Sending Office: Honorable F. James Sensenbrenner, Jr.
Please join us in supporting H.R. 3396, The Functional Gastrointestinal and Motility Disorders Research Enhancement Act.
Functional gastrointestinal and motility disorders (FGIMDs) are among the most common health disorders in the general population. These conditions can affect any part of the digestive tract, including the esophagus, stomach, and the small and large intestines.
FGIMDs are typically classified by symptoms related to any combination of the following: motility disturbance, visceral hypersensitivity, altered mucosal and immune function, altered gut microbiota, and altered central nervous system (CNS) processing.
Symptoms of these disorders can be disabling and in some instances life-threatening, and few effective therapies exist. Treatment generally focuses on management of complex symptoms over a long term. Some examples of functional gastrointestinal disorders
are: dyspepsia, gastroparesis, irritable bowel syndrome, gastroesophageal reflux disease, bowel incontinence, and cyclic vomiting syndrome. Patients with FGIMDs can suffer for years before receiving a diagnosis and only have access to few effective treatments
due to a lack of proper education for physicians.
Representatives Jim Sensenbrenner and Gwen Moore have reintroduced The Functional Gastrointestinal and Motility Disorders Research Enhancement Act
to expand, advance, and better coordinate NIH research activities for FGIMDs and support innovative approaches to educating patients and health care providers about strategies that improve care.
To cosponsor, or if you have any questions, please contact:
- Ben Steinhafel (Rep. Jim Sensenbrenner) at
email@example.com or 5-5101
- Caroline Frauman (Rep. Gwen Moore) at
firstname.lastname@example.org or 5-4572
F. James Sensenbrenner, Jr. Gwen Moore
U.S. House of Representatives U.S. House of Representatives
e-Dear Colleague version 2.0